Syros Pharmaceuticals's Return On Capital Employed Overview
March 08, 2023 at 09:46 AM EST
According to data from Benzinga Pro, during Q4, Syros Pharmaceuticals's (NASDAQ:SYRS) reported sales totaled $-754 thousand. Despite a ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.